Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.09014 | 45 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.22207 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.22358 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.15945 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.17097 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.42589 | 54 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.33697 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.53868 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.21243 | 51 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.18761 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.20823 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.22931 | 52 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.0183 | 44 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.21132 | 51 |